Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC), accounting for 70–80% of all renal cell carcinomas, is a common malignancy. Survival rates decrease significantly in patients with advanced and metastatic ccRCC. Furthermore, ccRCC is less responsive to radiation and chemotherapy than other cancers. Therefore...
Main Authors: | Kai Zeng, Guoda Song, Bingliang Chen, Xintao Gao, Chaofan Liu, Jianping Miao, Yajun Ruan, Yang Luan, Xin Chen, Jihong Liu, Qinyu Li, Bo Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332200184X |
Similar Items
-
STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma
by: Kai Zeng, et al.
Published: (2024-01-01) -
Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01) -
Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma
by: Corina Daniela Ene, et al.
Published: (2023-12-01) -
The Impact of Image Acquisition Parameters and ComBat Harmonization on the Predictive Performance of Radiomics: A Renal Cell Carcinoma Model
by: Abdalla Ibrahim, et al.
Published: (2022-09-01) -
The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma
by: Wenjie Yang, et al.
Published: (2024-03-01)